STOCK TITAN

Soleus entities disclose sub-5% Invivyd (IVVD) stake totaling 7.7M shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Invivyd, Inc. (IVVD) received an amended Schedule 13G showing that a group of Soleus-affiliated investment entities and Guy Levy collectively report beneficial ownership below 5% of its common stock. The filing is based on an event dated December 31, 2025.

Soleus Private Equity Fund III, L.P. and related Soleus private equity entities each report beneficial ownership of 1,680,160 shares, representing 0.6% of Invivyd’s common stock. Separately, Soleus Capital Master Fund, L.P. and related Soleus capital entities each report 6,028,567 shares, or 2.2% of the class.

Soleus Capital Management, L.P., Soleus GP, LLC and Guy Levy each report beneficial ownership of 7,708,727 shares, equal to 2.8% of Invivyd’s outstanding common stock, all with shared and no sole voting or dispositive power. The percentages are calculated using 277,064,852 Invivyd shares outstanding immediately after an underwritten offering described in a prospectus supplement. The reporting persons state the securities were not acquired and are not held for the purpose of changing or influencing control of Invivyd.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Soleus Private Equity Fund III, L.P. ("Soleus PE"). Soleus Private Equity GP III, LLC ("Soleus PE GP") is the sole general partner of Soleus PE, Soleus PE GP III, LLC is the sole manager of Soleus PE GP, Soleus Capital Management, L.P. ("SCM") is the investment manager for Soleus PE and for Soleus Capital Master Fund, L.P. ("Master Fund"), and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP III, LLC and of Soleus GP, LLC. Each of Mr. Levy, Soleus PE GP III, LLC, Soleus PE GP, SCM and Soleus GP, LLC disclaims beneficial ownership of these shares held by Soleus PE other than for the purpose of determining their obligations under Section 13(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 277,064,852 shares of the common stock of Invivyd, Inc. (the "Issuer") outstanding immediately following the closing of the underwritten offering of the Issuer's common stock as described in the Issuer's prospectus supplement dated November 17, 2025 that was filed with the Securities and Exchange Commission on November 19, 2025 (the "Prospectus Supplement").


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Soleus PE. Soleus PE GP is the sole general partner of Soleus PE, Soleus PE GP III, LLC is the sole manager of Soleus PE GP, SCM is the investment manager for Soleus PE and for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP III, LLC and of Soleus GP, LLC. Each of Mr. Levy, Soleus PE GP III, LLC, Soleus PE GP, SCM and Soleus GP, LLC disclaims beneficial ownership of these shares held by Soleus PE other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 277,064,852 shares of common stock of the Issuer outstanding immediately following the closing of the underwritten offering of the Issuer's common stock as described in the Prospectus Supplement.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Soleus PE. Soleus PE GP is the sole general partner of Soleus PE, Soleus PE GP III, LLC is the sole manager of Soleus PE GP, SCM is the investment manager for Soleus PE and for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP III, LLC and of Soleus GP, LLC. Each of Mr. Levy, Soleus PE GP III, LLC, Soleus PE GP, SCM and Soleus GP, LLC disclaims beneficial ownership of these shares held by Soleus PE other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 277,064,852 shares of common stock of the Issuer outstanding immediately following the closing of the underwritten offering of the Issuer's common stock as described in the Prospectus Supplement.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Master Fund. Soleus Capital, LLC is the sole general partner of Master Fund, Soleus Capital Group, LLC ("SCG") is the sole managing member of Soleus Capital, LLC, SCM is the investment manager for Soleus PE and for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, LLC, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 277,064,852 shares of common stock of the Issuer outstanding immediately following the closing of the underwritten offering of the Issuer's common stock as described in the Prospectus Supplement.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Master Fund. Soleus Capital, LLC is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, LLC, SCM is the investment manager for Soleus PE and for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, LLC, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 277,064,852 shares of common stock of the Issuer outstanding immediately following the closing of the underwritten offering of the Issuer's common stock as described in the Prospectus Supplement.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Master Fund. Soleus Capital, LLC is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, LLC, SCM is the investment manager for Soleus PE and for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, LLC, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 277,064,852 shares of common stock of the Issuer outstanding immediately following the closing of the underwritten offering of the Issuer's common stock as described in the Prospectus Supplement.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Soleus PE and by Master Fund. Soleus PE GP is the sole general partner of Soleus PE, Soleus PE GP III, LLC is the sole manager of Soleus PE GP, SCM is the investment manager for Soleus PE, and Soleus GP, LLC is the sole general partner of SCM. Soleus Capital, LLC is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, LLC, SCM is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP III, LLC, SCG and Soleus GP, LLC. Each of Soleus PE GP, Soleus PE GP III, LLC, Soleus Capital, LLC, SCG, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held directly by Soleus PE and Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 277,064,852 shares of common stock of the Issuer outstanding immediately following the closing of the underwritten offering of the Issuer's common stock as described in the Prospectus Supplement.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Soleus PE and by Master Fund. Soleus PE GP is the sole general partner of Soleus PE, Soleus PE GP III, LLC is the sole manager of Soleus PE GP, SSCM is the investment manager for Soleus PE, and Soleus GP, LLC is the sole general partner of SCM. Soleus Capital, LLC is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, LLC, SCM is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP III, LLC, SCG and Soleus GP, LLC. Each of Soleus PE GP, Soleus PE GP III, LLC, Soleus Capital, LLC, SCG, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held directly by Soleus PE and Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 277,064,852 shares of common stock of the Issuer outstanding immediately following the closing of the underwritten offering of the Issuer's common stock as described in the Prospectus Supplement.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Soleus PE and by Master Fund. Soleus PE GP is the sole general partner of Soleus PE, Soleus PE GP III, LLC is the sole manager of Soleus PE GP, SCM is the investment manager for Soleus PE, and Soleus GP, LLC is the sole general partner of SCM. Soleus Capital, LLC is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, LLC, SCM is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP III, LLC, SCG and Soleus GP, LLC. Each of Soleus PE GP, Soleus PE GP III, LLC, Soleus Capital, LLC, SCG, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held directly by Soleus PE and Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 277,064,852 shares of common stock of the Issuer outstanding immediately following the closing of the underwritten offering of the Issuer's common stock as described in the Prospectus Supplement.


SCHEDULE 13G



Soleus Private Equity Fund III, L.P.
Signature:/s/ Guy Levy
Name/Title:Guy Levy/Managing Member
Date:02/12/2026
Soleus Private Equity GP III, LLC
Signature:/s/ Guy Levy
Name/Title:Guy Levy/Managing Member
Date:02/12/2026
Soleus PE GP III, LLC
Signature:/s/ Guy Levy
Name/Title:Guy Levy/Managing Member
Date:02/12/2026
Soleus Capital Master Fund, L.P.
Signature:/s/ Guy Levy
Name/Title:Guy Levy/Managing Member
Date:02/12/2026
Soleus Capital, LLC
Signature:/s/ Guy Levy
Name/Title:Guy Levy/Managing Member
Date:02/12/2026
Soleus Capital Group, LLC
Signature:/s/ Guy Levy
Name/Title:Guy Levy/Managing Member
Date:02/12/2026
Soleus Capital Management, L.P.
Signature:/s/ Guy Levy
Name/Title:Guy Levy/Managing Member
Date:02/12/2026
Soleus GP, LLC
Signature:/s/ Guy Levy
Name/Title:Guy Levy/Managing Member
Date:02/12/2026
Guy Levy
Signature:/s/ Guy Levy
Name/Title:Guy Levy
Date:02/12/2026

FAQ

What ownership stake in Invivyd (IVVD) does the Soleus group report?

The Soleus group reports beneficial ownership of up to 7,708,727 Invivyd shares, or 2.8% of the company’s common stock. This reflects positions held through Soleus Private Equity Fund III, L.P., Soleus Capital Master Fund, L.P., and related management entities.

How many Invivyd (IVVD) shares does Soleus Capital Master Fund, L.P. hold?

Soleus Capital Master Fund, L.P. reports beneficial ownership of 6,028,567 Invivyd common shares, representing 2.2% of the outstanding class. Related entities Soleus Capital, LLC and Soleus Capital Group, LLC report the same number of shares and percentage with shared voting and dispositive power.

What percentage of Invivyd (IVVD) does Guy Levy report beneficially owning?

Guy Levy reports beneficial ownership of 7,708,727 Invivyd shares, equal to 2.8% of the company’s common stock. These shares are held through Soleus Private Equity Fund III, L.P. and Soleus Capital Master Fund, L.P., with only shared voting and dispositive power reported.

On what share count is the Soleus ownership percentage in Invivyd (IVVD) based?

The reported ownership percentages are calculated using 277,064,852 Invivyd common shares outstanding. This share count reflects the amount outstanding immediately after an underwritten offering described in Invivyd’s prospectus supplement dated November 17, 2025.

Did the Soleus group acquire Invivyd (IVVD) shares to influence control of the company?

The reporting persons certify the Invivyd shares were not acquired and are not held to change or influence control. They state the holdings are not part of any transaction with that purpose, other than activities solely related to a nomination under the relevant proxy rule.

Does any Soleus entity report sole voting power over Invivyd (IVVD) shares?

No Soleus entity reports sole voting or sole dispositive power over Invivyd shares. All listed reporting persons show 0 shares with sole power and instead report only shared voting and shared dispositive power over their respective Invivyd positions.
Invivyd

NASDAQ:IVVD

IVVD Rankings

IVVD Latest News

IVVD Latest SEC Filings

IVVD Stock Data

454.00M
228.39M
19.2%
60.75%
2.52%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
NEW HAVEN